文献速递胃肠外科围术期管理与 ERAS

结直肠手术当日使用加巴喷丁类药物与术后不良呼吸结局的关联

Association 'Between Gabapentinoids on the Day of Colorectal Surgery and Adverse Postoperative Respiratory Outcomes.
PubMed 文献 · Ann Surg · 2019-01-01

该回顾性研究利用Premier数据库纳入2009至2014年175,787例择期结直肠手术患者,评估手术当日使用加巴喷丁类药物与术后不良结局的关联。结果显示用药与手术当日阿片类药物用量轻度降低相关,但与非侵入性通气及纳洛酮使用几率升高相关。

要点

  • 结直肠手术当日使用加巴喷丁类药物与术后非侵入性通气几率升高相关。
  • 用药与术后纳洛酮使用几率升高相关,提示呼吸抑制风险。
  • 用药与手术当日阿片类药物用量轻度降低相关,但无创通气风险增加。

核心结论

  • 手术当日使用加巴喷丁类药物虽与手术当日阿片类药物用量轻度降低相关,但与术后非侵入性通气和纳洛酮使用几率升高相关。

研究设计与样本

  • 回顾性研究,利用Premier数据库纳入2009至2014年175,787例择期结直肠手术患者。
  • 采用多水平回归模型评估加巴喷丁类药物暴露与术后结局的关联。

主要发现

  • 总体4677例(2.7%)患者在手术当日接受加巴喷丁类药物,使用率从2009年1.7%增至2014年4.3%。
  • 与未暴露患者相比,暴露患者手术当日阿片类药物用量更低(-2.7 mg;95%CI -5.2至-0.0 mg)。
  • 暴露患者非侵入性通气几率更高(OR 1.22,95%CI 1.00-1.49),纳洛酮使用几率更高(OR 1.58,95%CI 1.11-2.26)。
  • 两组在侵入性通气或出院前一日阿片类药物用量方面无差异。

临床怎么用

  • 结直肠手术围术期使用加巴喷丁类药物时应权衡呼吸抑制风险,尤其关注非侵入性通气和纳洛酮使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to determine the association between gabapentinoids on the day of surgery and adverse postoperative outcomes in patients undergoing colorectal surgery in the United States. BACKGROUND: Gabapentinoids, gabapentin and pregabalin, are recommended in multimodal analgesia protocols for acute postoperative pain management after colorectal surgery. However, current literature focuses on the efficacy in reducing opioid consumption, but provides limited information about adverse risks. METHODS: This was a retrospective study including 175,787 patients undergoing elective colorectal surgery using the Premier database between 2009 and 2014. Multilevel regression models measured associations of receipt of gabapentinoids with naloxone use after surgery, non-invasive ventilation (NIV), invasive ventilation (IMV), hospital length of stay (LOS), and parental morphine equivalents (PMEs) on the day of surgery and on the day before discharge. RESULTS: Overall, 4677 (2.7%) patients received gabapentinoids on the day of surgery, with use doubling (1.7% in 2009 to 4.3% in 2014). Compared with patients who were unexposed to ganapentinoids, gabapentinoid exposure was associated with lower PMEs on the day of surgery [-2.7 mg; 95% confidence interval (CI), -5.2 to -0.0 mg], and with higher odds of NIV [odds ratio (OR) 1.22, 95% CI, 1.00-1.49] and receipt of naloxone (OR 1.58, 95% CI, 1.11-2.26). There was no difference between the groups with respect to IMV or PMEs on the day before discharge. CONCLUSIONS: Although use of gabapentinoids on the day of surgery was associated with slightly lower PMEs on the day of surgery, it was associated with higher odds of NIV and naloxone use after surgery.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Ohnuma T, Krishnamoorthy V, Ellis AR, et al. Association 'Between Gabapentinoids on the Day of Colorectal Surgery and Adverse Postoperative Respiratory Outcomes. Ann Surg. 2019. PMID: 30985370. doi:10.1097/SLA.0000000000003317

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。